Nantahala Capital Management, LLC

Position in ABVX — Abivax S.A.

CIK 1472322 New Canaan, CT

Position in ABVX

as of Jun 30, 2026 · filed Aug 19, 2026 Compact

Position Value

$17,824,724

+$2,543,385 QoQ

Shares Held

133,759

-2.5% QoQ

Ownership

0.153%

of shares outstanding

% of Portfolio

1.08%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Nantahala Capital Management, LLC holds $620,287,047 across 52 Biotechnology names. ABVX ranks #14 (2.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SVRA	Savara Inc	6,976,810	$42,977,149
2	AVTX	Avalo Therapeutics, Inc.	1,862,250	$34,414,380
3	LBRX	Lb Pharmaceuticals Inc	1,052,894	$34,171,674
4	ABEO	Abeona Therapeutics Inc.	5,136,490	$31,743,508
5	ZVRA	Zevra Therapeutics, Inc.	1,797,476	$25,775,805
6	MLYS	Mineralys Therapeutics, Inc.	820,481	$22,136,577
7	QURE	uniQure N.V.	455,660	$20,987,699
8	AURA	Aura Biosciences, Inc.	2,951,030	$20,952,313

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$17,824,724	133,759	-2.5%	Shares	Sole	2026-08-19
2026-03-31	$15,281,339	137,237	-10.4%	Shares	Sole	2026-05-15
2025-12-31	$20,664,505	153,235	-72.5%	Shares	Sole	2026-02-13
2025-09-30	$47,337,183	557,564	-62.4%	Shares	Sole	2025-11-14
2025-06-30	$11,344,904	1,482,994	0.0%	Shares	Sole	2025-08-14
2025-03-31	$9,268,712	1,482,994	+3.3%	Shares	Sole	2025-05-15
2024-12-31	$10,511,864	1,436,047	+45.7%	Shares	Sole	2025-02-14
2024-09-30	$11,354,503	985,634	0.0%	Shares	Sole	2024-11-14
2024-06-30	$13,030,081	985,634	-2.4%	Shares	Sole	2024-08-20
2024-03-31	$14,443,486	1,010,034	0.0%	Shares	Sole	2024-05-15
2023-12-31	$10,807,363	1,010,034	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.